tm logo
Trademark Search
EVERY IMMUNE SYSTEM HAS A STORY TO TELL. THE KEY IS KNOWING HOW TO LISTEN.

View On IC.GC.CA

EVERY IMMUNE SYSTEM HAS A STORY TO TELL. THE KEY IS KNOWING HOW TO LISTEN.
REGISTERED

on 09 Aug 2024

Last Applicant/ Owned by

ADAPTIVE BIOTECHNOLOGIES CORP.

1551 Eastlake Avenue E, Suite 200Seattle WA 98102

US

Serial Number

2138249 filed on 09th Jul 2021

Registration Number

TMA1249494 registered on 09th Aug 2024

Registration expiry Date

09th Jul 2031

Correspondent Address

SUITE 2308120 ADELAIDE STREET WESTTORONTO

ONTARIO

CA

M5H1T1

EVERY IMMUNE SYSTEM HAS A STORY TO TELL. THE KEY IS KNOWING HOW TO LISTEN.

Trademark usage description

providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evalua Read More

Classification Information

Class [042]
Providing medical diagnostic assays and diagnostic and prognostic testing for medical research purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals for research purposes; development of new technology for others in the field of medical biotechnology; DNA analysis services for scientific research purposes; genetic testing for scientific research purposes; genome amplification; genotyping services for research or analysis purposes; laboratory research in the field of immune sequencing; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of immune sequencing; providing laboratory research services in the field of gene expression, namely, cancer biology; providing medical and scientific research information in the field of clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and medical biotechnology fields; research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; scientific research in the field of genetics and genetic engineering; DNA screening for scientific research purposes; medical research; consulting services in the fields of medical biotechnology, pharmaceutical research and development and genetic science; consulting services in the fields of medical biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; custom design and development of chemical reagents and biochemical assays; research and development in the field of immunopharmaceuticals; research and development services in the field of immunology; laboratory research in the field of immunotherapy, oncology, hematology, auto-immune disorders, and infectious diseases; medical and scientific research in the field of immunotherapy; medical laboratory services

Classification kind code

11

Class [044]
Providing medical diagnostic assays and diagnostic and prognostic testing for treatment purposes of residual disease, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; consulting services in the field of medical diagnostic and prognostic testing; medical testing services relating to the diagnosis and treatment of disease; providing medical diagnostic and prognostic testing services

Classification kind code

11

Mark Details

Serial Number

2138249

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 48
on 26th Jul 2023		Agent Changed
Submitted for opposition 22
on 27th Jan 2023		Search Recorded
Submitted for opposition 20
on 27th Jan 2023		Examiner's First Report
Submitted for opposition 223
on 27th Jan 2023		Total Provisional Refusal
Submitted for opposition 256
on 08th Aug 2022		Notification of Possible Opposition Sent
Submitted for opposition 257
on 07th Oct 2021		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 06th Oct 2021		Formalized
Submitted for opposition 1
on 06th Oct 2021		Created
Submitted for opposition 228
on 09th Jul 2021		International Registration
Submitted for opposition 30
on 09th Jul 2021		Filed